Correlation Between HEMISPHERE EGY and CRISPR Therapeutics
Can any of the company-specific risk be diversified away by investing in both HEMISPHERE EGY and CRISPR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HEMISPHERE EGY and CRISPR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HEMISPHERE EGY and CRISPR Therapeutics AG, you can compare the effects of market volatilities on HEMISPHERE EGY and CRISPR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HEMISPHERE EGY with a short position of CRISPR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HEMISPHERE EGY and CRISPR Therapeutics.
Diversification Opportunities for HEMISPHERE EGY and CRISPR Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between HEMISPHERE and CRISPR is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding HEMISPHERE EGY and CRISPR Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CRISPR Therapeutics and HEMISPHERE EGY is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HEMISPHERE EGY are associated (or correlated) with CRISPR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CRISPR Therapeutics has no effect on the direction of HEMISPHERE EGY i.e., HEMISPHERE EGY and CRISPR Therapeutics go up and down completely randomly.
Pair Corralation between HEMISPHERE EGY and CRISPR Therapeutics
If you would invest 121.00 in HEMISPHERE EGY on November 2, 2024 and sell it today you would earn a total of 1.00 from holding HEMISPHERE EGY or generate 0.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
HEMISPHERE EGY vs. CRISPR Therapeutics AG
Performance |
| Timeline |
| HEMISPHERE EGY |
| CRISPR Therapeutics |
HEMISPHERE EGY and CRISPR Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HEMISPHERE EGY and CRISPR Therapeutics
The main advantage of trading using opposite HEMISPHERE EGY and CRISPR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HEMISPHERE EGY position performs unexpectedly, CRISPR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will offset losses from the drop in CRISPR Therapeutics' long position.| HEMISPHERE EGY vs. HELIOS TECHS INC | HEMISPHERE EGY vs. Addtech AB | HEMISPHERE EGY vs. Playtech plc | HEMISPHERE EGY vs. Carnegie Clean Energy |
| CRISPR Therapeutics vs. NEWELL RUBBERMAID | CRISPR Therapeutics vs. ULTRA CLEAN HLDGS | CRISPR Therapeutics vs. Mitsubishi Materials | CRISPR Therapeutics vs. GREENX METALS LTD |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |